India · Delayed Price · Currency is INR Theseus Pharmaceuticals Statistics
Total Valuation
NSE:CCL has a market cap or net worth of INR 115.11 billion. The enterprise value is 132.29 billion.
| Market Cap | 115.11B |
| Enterprise Value | 132.29B |
Important Dates
The last earnings date was Tuesday, August 5, 2025.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | Aug 7, 2025 |
Share Statistics
| Current Share Class | 133.53M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | -0.12% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 69.46M |
Valuation Ratios
The trailing PE ratio is 36.98 and the forward PE ratio is 29.27.
| PE Ratio | 36.98 |
| Forward PE | 29.27 |
| PS Ratio | 3.39 |
| PB Ratio | 5.85 |
| P/TBV Ratio | 5.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 42.49 |
| EV / Sales | 3.90 |
| EV / EBITDA | 23.64 |
| EV / EBIT | 28.63 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.92 |
| Debt / EBITDA | 3.24 |
| Debt / FCF | n/a |
| Interest Coverage | 3.82 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 8.16% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 25.00M |
| Profits Per Employee | 2.29M |
| Employee Count | 1,358 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:CCL has paid 479.44 million in taxes.
| Income Tax | 479.44M |
| Effective Tax Rate | 13.35% |
Stock Price Statistics
The stock price has increased by +40.40% in the last 52 weeks. The beta is 0.03, so NSE:CCL's price volatility has been lower than the market average.
| Beta (5Y) | 0.03 |
| 52-Week Price Change | +40.40% |
| 50-Day Moving Average | 859.38 |
| 200-Day Moving Average | 714.52 |
| Relative Strength Index (RSI) | 63.12 |
| Average Volume (20 Days) | 275,294 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:CCL had revenue of INR 33.96 billion and earned 3.11 billion in profits. Earnings per share was 23.34.
| Revenue | 33.96B |
| Gross Profit | 12.60B |
| Operating Income | 4.62B |
| Pretax Income | 3.59B |
| Net Income | 3.11B |
| EBITDA | 5.60B |
| EBIT | 4.62B |
| Earnings Per Share (EPS) | 23.34 |
Balance Sheet
The company has 969.43 million in cash and 18.15 billion in debt, giving a net cash position of -17.18 billion.
| Cash & Cash Equivalents | 969.43M |
| Total Debt | 18.15B |
| Net Cash | -17.18B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 19.67B |
| Book Value Per Share | 147.33 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 37.12%, with operating and profit margins of 13.61% and 9.17%.
| Gross Margin | 37.12% |
| Operating Margin | 13.61% |
| Pretax Margin | 10.58% |
| Profit Margin | 9.17% |
| EBITDA Margin | 16.48% |
| EBIT Margin | 13.61% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.54%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 0.54% |
| Dividend Growth (YoY) | 11.11% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.02% |
| Shareholder Yield | 0.52% |
| Earnings Yield | 2.70% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 19, 2013. It was a forward split with a ratio of 10.
| Last Split Date | Aug 19, 2013 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |